Establishing Novel Imaging Biomarkers of ADPKD to Identify Rapidly Progressive Patients
Time: 12:00 pm
day: Track 1 - Day 1 AM
Details:
- Optimizing total kidney volume (TKV) to accurately predict eGFR decline
- Uncovering opportunities to identify treatable patients with ADPKD earlier in disease progression
- Negotiating challenges in TKV from the payer to the regulator
